Language
English
Publication Date
2011
Journal
The Texas Heart Institute Journal
PMID
22163124
PMCID
PMC3231541
PubMedCentral® Posted Date
2011
PubMedCentral® Full Text Version
Post-Print
Abstract
Conflicting patient outcomes have been reported after the use of sirolimus-eluting stents or bare-metal stents. In this nonrandomized study, we examine the outcomes after placement of sirolimus-eluting versus bare-metal stents in an unselected population of patients who underwent percutaneous coronary revascularization.
We used THIRD-base, a longitudinal data registry of patients who underwent revascularization at our institution, to compare demographics and outcomes in patients treated with a sirolimus-eluting or bare-metal stent from January 2001 through June 2006. Outcome measures included major acute coronary and cerebral events at 30 days, target-vessel failure at 9 months and at 3 years, and stent thrombosis. Target-vessel failure was defined as the composite of all-cause death, recurrent myocardial infarction in the treated vessel distribution, and target-vessel revascularization. Logistic regression and Cox proportional regression models were used to determine the predictors of outcome.
Of the 6,425 patients analyzed, 2,581 patients (40.2%) received only sirolimus-eluting stents, and 3,844 patients (59.8%) received only bare-metal stents. Early major acute coronary and cerebral events and stent thrombosis at 30 days and 9 months were similar in both groups. Target-vessel failure was less frequent in sirolimus-eluting stent patients than in bare-metal stent patients at 9 months (4.84% vs 11.81%, P < 0.0001) and at 3 years (29% vs 32%, P < 0.0001).
Use of sirolimus-eluting stents improved target-vessel failure survival at 9 months and at 3 years. Late adverse events were determined by known risk factors for atherosclerosis, not by stent type.
Keywords
Angioplasty, balloon, coronary; bare-metal stents/statistics & numerical data; coronary restenosis/prevention & control; drug delivery systems; drug-eluting stents/statistics & numerical data; hyperplasia/prevention & control; immunosuppressive agents; sirolimus/therapeutic use; thrombosis/prevention & control
Published Open-Access
yes
Recommended Citation
Munir, Muhammad; Aliota, Jonathan; Ahmed, Amany; et al., "Sirolimus-Eluting Stents versus Bare-Metal Stents in Routine Clinical Use" (2011). The Texas Heart Institute Journal. 372.
https://digitalcommons.library.tmc.edu/texasheartinstituejournal/372